Outpatient treatment of deep venous thrombosis: A clinical care pathway managed by the emergency department

Annals of Emergency Medicine

Volumn 37, Issue 3, 2001, Pages 251-258

  Vinson, David R ^a,b   Berman, David A ^a,b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE EXACERBATION; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL;

EID: 0035091924     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2001.113703     Document Type: Article

References (27)

1. Antithrombetic therapy for venous thromboembolic disease
2. New-generation anticoagulants: The low molecular weight heparins
3. Low-molecular-weight heparins
4. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: Examining some unanswered questions regarding location of treatment, product type, and dosing frequency
5. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
6. Treatment of thrombosis with intravenous unfractionated heparin administered in the hospital with subcutaneous low-molecular-weight heparin administered at home
7. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
8. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
9. Economic evaluation of outpatient treatment with lowmolecular-weight heparin for proximal vein thrombosis
10. Out-of-hospital treatment of venous thrombosis: Socioeconomic aspects and patients' quality of life
11. Assessment of outpatient treatment of deep vein thrombosis with low-molecular-weight heparin
12. Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis
13. Low-molecular-weight heparins compared with unfractionated heparin for treatment of deep venous thrombosis: A cost-effectiveness analysis
14. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis
15. Outpatient treatment of deep vein thrombosis: Translating clinical trials into practice
16. Low-molecular-weight heparin in the emergency department treatment of venous thromboembolism
17. Hemorrhagic complications of anticoagulant treatment
18. Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving
19. Low-molecular-weight heparin - An opportunity for home treatment of venous thromboembolism
20. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin
21. An outpatient program to treat deep venous thrombosis with low-molecular-weight heparin
22. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism
23. Outpatient treatment of pulmonary embolism with dalteparin
24. Systematic lung scans reveal a high frequency of silent pulmonary emboli in patients with proximal deep venous thrombosis
25. Continuing care in the community
26. If nothing goes wrong, is everything all richt? Interpreting zero numerators